PORTENT Point-of-Care Diagnostics Weekly
PORTENT Point-of-Care Diagnostics Weekly is a concise briefing on the technologies, research, industry developments, regulatory milestones, and POCTRN+ activities shaping point-of-care diagnostics. The podcast is intended for researchers, innovators, clinicians, and industry leaders. In the pilot episode, the podcast examines continuous glucose and ketone sensing, an ambitious molecular STI-testing program, fingerstick monitoring of vancomycin, and a new approach to one-pot CRISPR diagnostics. The episode also considers Roche’s recently cleared Alzheimer’s blood test and provides an update on POCTRN+ Innovation Award activities.
PORTENT advances promising Point of Care technologies through:
Technology Development | Human Validation | User and Developer Training and Rotations | Commercialization
PORTENT translates breakthrough point-of-care diagnostics into rapid, affordable tests that reduce the burden of chronic disease, curb infectious threats, and strengthen prevention efforts across the United States. By integrating technology development with clinical validation, training, and lab-to-market programs, PORTENT accelerates earlier detection of conditions – from diabetes, heart disease to emerging infections – so providers can intervene sooner, patients stay healthier, and health care costs decline.
OUR GLOBAL PRESENCE
The PORTENT Center is unique as it:
Focuses on primary health care globally
Addresses the needs of the most vulnerable in the US and internationally
Enables validation of diagnostic technologies on a global range of populations and with a unique set of users
Develops expertise and strengthens capacity worldwide to have the most impact even beyond the center
One-of-a-kind international network of clinical, training, and device development facilities
Unique worldwide expertise in Point of Care diagnostics, their application and commercialization
Integrated clinical core and validation facilities across four continents: North America (United States), Africa (Uganda), South America (Ecuador) and Asia (India)
APPROACH & RESOURCES
NEWS & EVENTS
Portable test could help distinguish Ebola, Lassa where lab testing is limited
September 21, 2026
Cornell researchers have developed a portable diagnostic test that can simultaneously detect and distinguish Ebola and Lassa, two serious viruses whose early symptoms can be difficult to tell apart….READ MORE
PORTENT-supported team from Case Western Reserve University receives $2.93 million in follow-on funding
August 12, 2026
A PORTENT-supported technology team from Case Western Reserve University has received a $2.93 million National Cancer Institute Academic-Industrial Partnership R01 award over five years to advance a rapid point-of-care test for oral cancer screening…….READ MORE
OUR PARTNERS
